Your session is about to expire
← Back to Search
The nitrous oxide group for Complex Regional Pain Syndrome
Study Summary
This trial is testing whether nitrous oxide is better than oxygen at reducing pain for people with a spinal cord stimulator.
- Complex Regional Pain Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research study only open to individuals who are under 30 years old?
"According to the age limits set out in this clinical trial's eligibility criteria, patients must be between 18 and 65 years old."
Who meets the criteria to take part in this experiment?
"Up to 44 individuals between the ages of 18-65 who have Complex Regional Pain Syndrome (CRPS) also known as Reflex Sympathetic Dystrophy (RSD) can be admitted into this trial. Importantly, these patients must have had RSD for a minimum of 6 months."
What medical conditions respond best to nitrous oxide therapy?
"Analgesia is commonly managed with nitrous oxide. Additionally, this gas can be used to mitigate other conditions like hypoxemia, general anesthesia, and anemia."
Are there risks associated with The nitrous oxide group?
"There is both prior clinical data supporting the safety of nitrous oxide and multiple rounds of supportive data, so it received a score of 3."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger